Patent · US Active

Nanoparticulate meloxicam formulations

US10471067B2 · kind B2 · utility

0Cited by
84References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2017
Grant dateNov 12, 2019
Priority date
Expiry dateFeb 21, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.